175 related articles for article (PubMed ID: 24319831)
1. Are there risks associated with empiric acid suppression treatment of infants and children suspected of having gastroesophageal reflux disease?
Chung EY; Yardley J
Hosp Pediatr; 2013 Jan; 3(1):16-23. PubMed ID: 24319831
[TBL] [Abstract][Full Text] [Related]
2. ANTISECRETORY TREATMENT FOR PEDIATRIC GASTROESOPHAGEAL REFLUX DISEASE - A SYSTEMATIC REVIEW.
Mattos ÂZ; Marchese GM; Fonseca BB; Kupski C; Machado MB
Arq Gastroenterol; 2017 Dec; 54(4):271-280. PubMed ID: 28954042
[TBL] [Abstract][Full Text] [Related]
3. Adverse effects reported in the use of gastroesophageal reflux disease treatments in children: a 10 years literature review.
Cohen S; Bueno de Mesquita M; Mimouni FB
Br J Clin Pharmacol; 2015 Aug; 80(2):200-8. PubMed ID: 25752807
[TBL] [Abstract][Full Text] [Related]
4. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children.
Canani RB; Cirillo P; Roggero P; Romano C; Malamisura B; Terrin G; Passariello A; Manguso F; Morelli L; Guarino A;
Pediatrics; 2006 May; 117(5):e817-20. PubMed ID: 16651285
[TBL] [Abstract][Full Text] [Related]
5. Association of inhibitors of gastric acid secretion and higher incidence of necrotizing enterocolitis in preterm very low-birth-weight infants.
More K; Athalye-Jape G; Rao S; Patole S
Am J Perinatol; 2013 Nov; 30(10):849-56. PubMed ID: 23359235
[TBL] [Abstract][Full Text] [Related]
6. A Review of Histamine-2 Receptor Antagonist and Proton Pump Inhibitor Therapy for Gastroesophageal Reflux Disease in Neonates and Infants.
Tan J; Jeffries S; Carr R
Paediatr Drugs; 2023 Sep; 25(5):557-576. PubMed ID: 37458926
[TBL] [Abstract][Full Text] [Related]
7. Safety of medication options for treating pediatric esophagitis.
Bardou M; Fortinsky KJ
Expert Opin Drug Saf; 2015 Jul; 14(7):1087-96. PubMed ID: 25913014
[TBL] [Abstract][Full Text] [Related]
8. [Gastroesophageal reflux disease: pathogenetic basis of differentiated tactics of treatment].
Tkachenko EI; Uspenskiĭ IuP; Karateev AE; Bakulin IG; Pakhomova IG
Eksp Klin Gastroenterol; 2009; (2):104-14. PubMed ID: 19552028
[TBL] [Abstract][Full Text] [Related]
9. Risk of post-stroke pneumonia with proton pump inhibitors, H2 receptor antagonists and mucoprotective agents: A retrospective nationwide cohort study.
Song TJ; Kim J
PLoS One; 2019; 14(5):e0216750. PubMed ID: 31067267
[TBL] [Abstract][Full Text] [Related]
10. Over-prescription of acid-suppressing medications in infants: how it came about, why it's wrong, and what to do about it.
Hassall E
J Pediatr; 2012 Feb; 160(2):193-8. PubMed ID: 22018908
[No Abstract] [Full Text] [Related]
11. Anti-reflux medication use in preterm infants.
Binti Abdul Hamid H; Szatkowski L; Budge H; Ojha S
Pediatr Res; 2022 Aug; 92(2):520-525. PubMed ID: 34716422
[TBL] [Abstract][Full Text] [Related]
12. Are proton pump inhibitors indicated for the treatment of gastroesophageal reflux in infants and children?
Rudolph CD
J Pediatr Gastroenterol Nutr; 2003; 37 Suppl 1():S60-4. PubMed ID: 14685080
[TBL] [Abstract][Full Text] [Related]
13. Esophagitis in children: an update on current pharmacotherapy.
Shashidhar H; Tolia V
Expert Opin Pharmacother; 2013 Dec; 14(18):2475-87. PubMed ID: 24138403
[TBL] [Abstract][Full Text] [Related]
14. Observational cohort study: safety outcomes in children using proton pump inhibitors or histamine-2 receptor antagonists.
Houben E; Johansson S; Nagy P; Penning-van Beest FJA; Kuipers EJ; Herings RMC
Curr Med Res Opin; 2018 Apr; 34(4):577-583. PubMed ID: 29149805
[TBL] [Abstract][Full Text] [Related]
15. H2-blocker therapy and necrotizing enterocolitis for very low birth weight preterm infants.
Lin HC; Su BH; Chen AC
Pediatrics; 2006 Oct; 118(4):1794-5; author reply 1795-6. PubMed ID: 17015576
[No Abstract] [Full Text] [Related]
16. Study Questions Use of Acid Suppressors to Curb Mild Infant Reflux.
Lyon J
JAMA; 2017 Oct; 318(15):1427-1428. PubMed ID: 28973122
[No Abstract] [Full Text] [Related]
17. Diagnosis and Treatment of Gastroesophageal Reflux in Infants and Children.
Baird DC; Harker DJ; Karmes AS
Am Fam Physician; 2015 Oct; 92(8):705-14. PubMed ID: 26554410
[TBL] [Abstract][Full Text] [Related]
18. Nizatidine for the treatment of pediatric gastroesophageal reflux symptoms: an open-label, multiple-dose, randomized, multicenter clinical trial in 210 children.
Orenstein SR; Gremse DA; Pantaleon CD; Kling DF; Rotenberg KS
Clin Ther; 2005 Apr; 27(4):472-83. PubMed ID: 15922820
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness and safety of proton pump inhibitors in infantile gastroesophageal reflux disease.
Higginbotham TW
Ann Pharmacother; 2010 Mar; 44(3):572-6. PubMed ID: 20124466
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of proton-pump inhibitors in children with gastroesophageal reflux disease: a systematic review.
van der Pol RJ; Smits MJ; van Wijk MP; Omari TI; Tabbers MM; Benninga MA
Pediatrics; 2011 May; 127(5):925-35. PubMed ID: 21464183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
